Cushing’s syndrome due to interaction between ritonavir or cobicistat and corticosteroids: a case–control study in the French Pharmacovigilance Database

MLA

Claire de Canecaude, et al. Cushing’s Syndrome Due to Interaction between Ritonavir or Cobicistat and Corticosteroids: A Case–control Study in the French Pharmacovigilance Database. Nov. 2019. EBSCOhost, https://doi.org/10.1093/jac/dkz324⟩.

APA

Claire de Canecaude, Jean-Jacques Parienti, Laure Peyro-Saint-Paul, Michel Biour, Sophie Fedrizzi, Ludivine Demessine, Paul Besnier, & Dominique Hillaire-Buys. (2019). Cushing’s syndrome due to interaction between ritonavir or cobicistat and corticosteroids: a case–control study in the French Pharmacovigilance Database. https://doi.org/10.1093/jac/dkz324⟩

Chicago

Claire de Canecaude, Jean-Jacques Parienti, Laure Peyro-Saint-Paul, Michel Biour, Sophie Fedrizzi, Ludivine Demessine, Paul Besnier, and Dominique Hillaire-Buys. 2019. “Cushing’s Syndrome Due to Interaction between Ritonavir or Cobicistat and Corticosteroids: A Case–control Study in the French Pharmacovigilance Database,” November. doi:10.1093/jac/dkz324⟩.